Literature DB >> 10931463

The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies.

M P Zeegers1, F E Tan, E Dorant, P A van Den Brandt.   

Abstract

BACKGROUND: Although narrative reviews have concluded that there is strong support for an association between cigarette smoking and urinary tract cancer, the association has never been quantified systematically in reviews. The purpose of this systematic review was to summarize and quantify the impact of different smoking characteristics (status, amount, duration, cessation, and age at first exposure) both unadjusted and adjusted for age and gender.
METHODS: The authors included 43 epidemiologic studies (8 cohort and 35 case-control) and calculated summary odds ratios (SORs) by meta-regression analyses for different smoking characteristics. They also evaluated changes in summary estimates according to differences in study methodology.
RESULTS: Smoking status and increased amount and duration of smoking were associated with a strong increased risk of urinary tract cancer. Smoking cessation and age at first exposure were negatively associated with the risk of urinary tract cancer. The age- and gender-adjusted SORs for current and former cigarette smokers compared with those for nonsmokers were 3.33 (95% confidence interval [CI], 2.63-4.21) and 1.98 (CI, 1.72-2.29), respectively. Even though the component studies differed in methodology, the results were rather consistent.
CONCLUSIONS: The results suggest a substantial increase in risk of cancer of the urinary tract for cigarette smokers. Based on the results of this study and previous literature, the authors conclude that current cigarette smokers have an approximately threefold higher risk of urinary tract cancer than nonsmokers. In Europe, approximately half of urinary tract cancer cases among males and one-third of cases among females might be attributable to cigarette smoking. Copyright 2000 American Cancer Society.

Entities:  

Mesh:

Year:  2000        PMID: 10931463     DOI: 10.1002/1097-0142(20000801)89:3<630::aid-cncr19>3.3.co;2-h

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  106 in total

Review 1.  The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review.

Authors:  Maurice P A Zeegers; Eliane Kellen; Frank Buntinx; Piet A van den Brandt
Journal:  World J Urol       Date:  2003-12-17       Impact factor: 4.226

2.  Impact of smoking status at diagnosis on disease recurrence and death in upper tract urothelial carcinoma.

Authors:  Behfar Ehdaie; Helena Furberg; Emily Craig Zabor; Jamie S Ostroff; Shahrokh F Shariat; Bernard H Bochner; Jonathan A Coleman; Guido Dalbagni
Journal:  BJU Int       Date:  2012-05-29       Impact factor: 5.588

Review 3.  Chemoprevention of bladder cancer.

Authors:  Dragan J Golijanin; David Kakiashvili; Ralph R Madeb; Edward M Messing; Seth P Lerner
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

4.  Differential DNA methylation in blood as a mediator of the association between cigarette smoking and bladder cancer risk among postmenopausal women.

Authors:  Kristina M Jordahl; Amanda I Phipps; Timothy W Randolph; Hilary A Tindle; Simin Liu; Lesley F Tinker; Karl T Kelsey; Emily White; Parveen Bhatti
Journal:  Epigenetics       Date:  2019-06-23       Impact factor: 4.528

5.  Substance-attributable morbidity and mortality changes to Canada's epidemiological profile: measurable differences over a ten-year period.

Authors:  Jayadeep Patra; Benjamin Taylor; Jürgen T Rehm; Dolly Baliunas; Svetlana Popova
Journal:  Can J Public Health       Date:  2007 May-Jun

Review 6.  Experimental animal model and RNA interference: a promising association for bladder cancer research.

Authors:  Leonardo Oliveira Reis; Tiago Campos Pereira; Wagner José Favaro; Valéria Helena Alves Cagnon; Iscia Lopes-Cendes; Ubirajara Ferreira
Journal:  World J Urol       Date:  2009-02-13       Impact factor: 4.226

7.  Association between polymorphisms in the biometabolism genes CYP1A1, GSTM1, GSTT1 and GSTP1 in bladder cancer.

Authors:  João Paulo Souto Grando; Hellen Kuasne; Roberta Losi-Guembarovski; Iara Sant'ana Rodrigues; Henrique Mitsu Matsuda; Paulo Emílio Fuganti; Emerson Pereira Gregório; Farid Libos Júnior; Rodrigo Paes de Menezes; Marco Aurélio de Freitas Rodrigues; Ilce Mara de Syllos Cólus
Journal:  Clin Exp Med       Date:  2008-11-01       Impact factor: 3.984

8.  Serum Metabolic Profiling Identified a Distinct Metabolic Signature in Bladder Cancer Smokers: A Key Metabolic Enzyme Associated with Patient Survival.

Authors:  Chandra Sekhar Amara; Chandrashekar R Ambati; Venkatrao Vantaku; Danthasinghe Waduge Badrajee Piyarathna; Sri Ramya Donepudi; Shiva Shankar Ravi; James M Arnold; Vasanta Putluri; Gurkamal Chatta; Khurshid A Guru; Hoda Badr; Martha K Terris; Roni J Bollag; Arun Sreekumar; Andrea B Apolo; Nagireddy Putluri
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-01-14       Impact factor: 4.254

9.  Genetic polymorphisms of glutathione S-transferase T1 and bladder cancer risk: a meta-analysis.

Authors:  Fang-Fang Zeng; Sheng-Yuan Liu; Wen Wei; Song-Po Yao; Shui Zhu; Ke-Shen Li; Gang Wan; Hai-Tao Zhang; Min Zhong; Bin-You Wang
Journal:  Clin Exp Med       Date:  2009-09-25       Impact factor: 3.984

Review 10.  Familial and genetic risk of transitional cell carcinoma of the urinary tract.

Authors:  Christine M Mueller; Neil Caporaso; Mark H Greene
Journal:  Urol Oncol       Date:  2008-06-18       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.